申请人:Gillespie Paul
公开号:US08404859B2
公开(公告)日:2013-03-26
Provided herein are compounds of the formula (I):
as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of inflammatory diseases and disorders such as, for example, asthma and COPD.
本文提供的是公式(I)的化合物及其药学上可接受的盐,其中取代基如规范中所披露的那样。这些化合物及其含有它们的药物组合物,可用于治疗炎症性疾病和疾病,例如哮喘和慢性阻塞性肺疾病。